Originator and biosimilar market dynamics

Godman, Brian (2021) Originator and biosimilar market dynamics. In: Biosimilars Latam - Brazil 2021, 2021-08-25 - 2021-08-26, Online Event.

Preview	Text. Filename: Godman_LATAM_2021_Originator_and_biosimilar_market.pdf Final Published Version Download (1MB)| Preview
Preview	Text. Filename: Biosimilars_Latam_Brazil_2021_overview.pdf Final Published Version Download (3MB)| Preview

Abstract

There is growing expenditure on medicines worldwide, estimated to reach US$1.5 trillion by 2023, with implications for affordability even in high income countries. This increase is driven by biological medicines for complex diseases, including cancer and orphan diseases , which are becoming unaffordable. The costs even for the anti TNFs has resulted in their limited prescribing among a number of Central and Eastern European countries, which is difficult to sustain. Biosimilars offer a way forward to improve the care of patients with proven similar effectiveness and safety between originators and biosimilars, e.g. NOR SWITCH study in Norway.

• Share and Export
  

  RDF+XMLBibTeXRIOXX2 XMLRDF+N-TriplesJSONDublin CoreAtomSimple MetadataReferMETSHTML CitationASCII CitationOpenURL ContextObjectEndNoteOpenURL ContextObject in SpanMODSMPEG-21 DIDLEP3 XMLData Cite XMLRIS (EndNote Online, Zotero, Ref manager, etc)RDF+N3Multiline CSV
• Item metadata

  Item type:	Conference or Workshop Item(Keynote)
  ID code:	77567
  Dates:	Date Event 25 August 2021 Published
  Subjects:	Medicine > Pharmacy and materia medica
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	26 Aug 2021 11:51
  Last modified:	11 Nov 2024 17:04
  Related URLs:	Event
  URI:	https://strathprints.strath.ac.uk/id/eprint/77567